Peptides in Skincare: Which Ones Actually Have Evidence — and Which Are Mostly a Marketing Word

There's a persistent idea that peptides are the "science-y" step in a routine — the biotech ingredient that makes a serum feel worth its price tag. It's a comforting story, and the marketing leans on it hard: chains of amino acids that "signal" collagen, "instruct" the skin, "communicate" with fibroblasts.

Some of that is true. The tricky part is that "peptides" is a category the size of a supermarket aisle, and the evidence inside that aisle ranges from a decent handful of trials to a single paper everyone quotes. If a serum promises "peptides", the honest question isn't whether peptides work — it's which peptide, in what formula, and does it actually reach where it needs to go.

What is a peptide, really?

A peptide is just a short chain of amino acids — smaller than a protein, bigger than a single amino acid. Skincare peptides usually fall into a few buckets:

• Signal peptides (like Matrixyl / palmitoyl pentapeptide-4): mimic fragments the skin naturally releases when collagen breaks down, prompting fibroblasts to make more of it.
• Neurotransmitter-inhibiting peptides (like Argireline / acetyl hexapeptide-8): claim to relax facial-muscle signalling — the "topical Botox" pitch.
• Carrier peptides (like GHK-Cu / copper peptides): shuttle trace minerals into the skin and act as signalling molecules for repair.
• Enzyme-inhibiting peptides: reduce the enzymes that degrade collagen.

They sound like distinct tools. In a jar, they mostly look the same — a milky serum with a lot of glycerin. That's the first useful thing to know: "peptide" on a label tells you almost nothing until you read which one.

Do peptides actually get through your skin?

This is the part most ads skip. The outer layer of your skin — the stratum corneum — is very good at keeping large water-loving molecules out. Peptides, being chains of amino acids, are exactly the kind of molecule it's designed to block.

Studies bear this out unevenly. A 2015 skin-permeability study found that after 24 hours, less than 0.2% of applied acetyl hexapeptide-8 (Argireline) had made it past the stratum corneum — and 99.7% could be washed off (Wikipedia summary of the 2015 Kraeling et al. penetration data). A 2025 review in the peer-reviewed Cosmetics literature noted the range across studies is huge — one in-vitro test found up to 30% penetration in two hours, another found 0.22% — and that "the amount of acetyl hexapeptide-8 in the stratum corneum decreased as it approached the living layers."

That's the honest picture. Whether a peptide works depends heavily on what it's dissolved in, whether it has a lipid tail attached, and how the vehicle is designed. This is why "palmitoyl-" prefixes matter — attaching a fatty tail transforms an otherwise impermeable peptide into one that can slip through skin lipids.

Matrixyl: the peptide with the most consistent data

Palmitoyl pentapeptide-4 — sold as Matrixyl — is probably the topical peptide with the strongest evidence, and its lipid tail is a big part of the reason.

An in-vitro study using human skin found palmitoyl pentapeptide-4 recovered at roughly 4.2 µg/cm² in the stratum corneum, 2.8 µg/cm² in the epidermis, and 0.3 µg/cm² in the dermis — small amounts, but demonstrably reaching living skin. Multiple double-blind, placebo-controlled trials have shown measurable wrinkle depth improvements over 28–56 days.

A 2023 study of a multi-peptide eye serum followed 32 women who completed 28 days of use. The formula combined acetyl hexapeptide-8, palmitoyl tripeptide-1, palmitoyl tetrapeptide-7 and dipeptide-2. Wrinkle measurements improved compared with the participants' own starting measurements, but there was no placebo comparison and the measured elasticity changes were not statistically significant. That's encouraging for the tested formula—not proof that every peptide serum works the same way.

That's the useful frame for signal peptides in general: small nudges to collagen signalling, on top of everything else your routine is doing — not standalone anti-ageing.

Argireline: what "Botox in a bottle" actually shows

Argireline (acetyl hexapeptide-8) is the peptide most associated with the "topical Botox" claim. The pitch: it interferes with the SNAP-25 protein involved in muscle-contraction signalling, so applied over expression lines it should soften them.

Here's the reality, as the 2025 Cosmetics review lays out: some in-vivo studies have reported wrinkle-depth reductions of up to about 49% after four weeks of daily use, which sounds impressive. But — and this is the reviewers' own conclusion — none of the in-vivo studies confirmed the peptide's supposed inhibitory effect on muscle contraction. Whatever softening people saw, it likely wasn't from "topical Botox" mechanics; it was probably a different pathway, possibly plain hydration.

Add the penetration numbers above, and the takeaway is: Argireline is not doing what the ad copy says it's doing. It may still contribute mildly to a well-formulated serum. It is not replacing an injection.

Copper peptides: promising, mostly thin

GHK-Cu (copper tripeptide-1) has a good in-vitro story: it binds to receptors involved in wound healing, boosts antioxidant enzyme activity, and stimulates collagen and elastin in cell studies. There are small clinical studies suggesting improvements in elasticity and skin density with topical use over months.

The important caveat: much of the strongest data is animal or in-vitro, and the human trials are small. A separate concern is that copper peptides have been showing up as injectable treatments online, well ahead of any safety or efficacy data for that route — a use case with no published human trial evidence to support it and real potential for harm.

For topical use in a normal serum, copper peptides are a reasonable ingredient with modest supporting evidence, not a miracle molecule.

How to read a peptide label without getting sold to

Two other things worth checking:

• Position on the ingredient list. In many peptide serums the peptides sit near the very bottom, meaning trace amounts. That isn't necessarily bad — some peptides are active at very low concentrations — but a "hero" ingredient below phenoxyethanol should temper expectations.
• Formulation. Peptides sit poorly with strong acids (a low-pH vitamin C can break them down). If you're using both, space them out — or use them on different nights.

What a peptide product can and can't realistically do

Peptides are worth including in a routine if you're already covering the fundamentals — sunscreen every morning, a retinoid at night if your skin tolerates it, some form of moisturiser. They add a small, well-studied nudge to collagen signalling in the case of signal peptides like Matrixyl. They probably do a bit of general repair signalling in the case of copper peptides.

They will not:

• Replace sunscreen. (Nothing does.)
• Deliver retinoid-sized results on fine lines.
• Actually relax facial muscles the way an injection does.
• Reverse deep, structural wrinkles that come from underlying volume loss.

The most honest way to think about peptides is as a supporting ingredient — useful in a well-designed serum, oversold when they're the only story a product tells.